Ai Cure Technologies sponsors and presents technology at Disruptive Innovations.

(Boston, MA) – September 19th, 2013 – Ai Cure Technologies, an artificial intelligence company providing advanced facial recognition solutions to monitor medication adherence, was invited to sponsor and present at the Third Annual Disruptive Innovations to Advance Clinical Trials conference in Boston. Adam Hanina, CEO of Ai Cure Technologies, presented the monitoring and intervention platform with an emphasis on how the technology fits in to the present competitive landscape, while highlighting the need for a new gold standard to be adopted in the real-time monitoring of medication adherence. The company exhibited its flagship facial recognition technology, the software-based platform AiView®.